DMK
PSTX

David M. Knott’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

David M. Knott’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$216K Hold
29,566
– – 0.08% 95
2021
Q2 		$296K Hold
29,566
– – 0.11% 90
2021
Q1 		$282K Buy
+29,566
New +$290K 0.12% 80

Other funds holding PSTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David M. Knott's PSTX Position: Q3 2021 in Review

David M. Knott held its Poseida Therapeutics, Inc. Common Stock (PSTX) position steady in Q3 2021 at 29,566 shares worth $216K. The position accounts for 0.08% of the portfolio, ranked #95.

David M. Knott first reported a position in PSTX in Q1 2021 and has held it in 3 quarters since. The position peaked at $296K in Q2 2021. 65 funds tracked by Wall St. Rank hold PSTX as of Q3 2021.

  • David M. Knott held 29,566 shares of Poseida Therapeutics, Inc. Common Stock worth $216K as of Q3 2021.
  • David M. Knott left its Poseida Therapeutics, Inc. Common Stock share count unchanged in Q3 2021.
  • Poseida Therapeutics, Inc. Common Stock made up 0.08% of David M. Knott's portfolio in Q3 2021, its #95 holding.
  • David M. Knott first reported a position in Poseida Therapeutics, Inc. Common Stock in Q1 2021 and has held it in 3 quarters since.
  • David M. Knott's Poseida Therapeutics, Inc. Common Stock position peaked at $296K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.